Article Versions Notes

Maines E, Franceschi R, Luppi G, Marchi G, Piccoli G, Vitturi N, Soffiati M, Campomori A, Urru SAM. Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. Metabolites. 2025; 15(7):427. https://doi.org/10.3390/metabo15070427

Maines, Evelina, Roberto Franceschi, Giacomo Luppi, Giacomo Marchi, Giovanni Piccoli, Nicola Vitturi, Massimo Soffiati, Annalisa Campomori, and Silvana Anna Maria Urru. 2025. "Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors" Metabolites 15, no. 7: 427. https://doi.org/10.3390/metabo15070427

Maines, E., Franceschi, R., Luppi, G., Marchi, G., Piccoli, G., Vitturi, N., Soffiati, M., Campomori, A., & Urru, S. A. M. (2025). Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. Metabolites, 15(7), 427. https://doi.org/10.3390/metabo15070427